Multi-omics based mechanistic study of Fufang Xuelian capsule in treating ankylosing spondylitis via the gut-joint axis.
Ankylosing spondylitis (AS) is a systemic autoimmune disease closely associated with gut microbiota dysbiosis. Fufang Xuelian Capsule (FXLC) has demonstrated clinical efficacy in treating AS; however, its underlying mechanism of action remains unclear. This study aimed to elucidate whether FXLC alleviates AS by modulat...